AngioDynamics ANGO Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from AngioDynamics’s reported figures.
Based on trailing twelve months.
The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about AngioDynamics's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AngioDynamics's return on equity?
- AngioDynamics (ANGO) reported return on equity of -17.5% in Q4 2025.
- How has AngioDynamics's return on equity changed year-over-year?
- AngioDynamics's return on equity increased by 14.6% year-over-year, from -20.5% to -17.5%.
- What is the long-term trend for AngioDynamics's return on equity?
- Over 4 years (2021 to 2025), AngioDynamics's return on equity has grown at a 25.5% compound annual growth rate (CAGR), from -7.1% to -17.5%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.